Cargando…

Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR)

BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe X-linked recessive disease caused by mutations in the dystrophin gene. Transplantation of myogenic stem cells holds great promise for treating muscular dystrophies. However, poor engraftment of myogenic stem cells limits the therapeutic effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhussieny, Ahmed, Nogami, Ken’ichiro, Sakai-Takemura, Fusako, Maruyama, Yusuke, Takemura, Natsumi, Soliman, Wael Talaat, Takeda, Shin’ichi, Miyagoe-Suzuki, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501581/
https://www.ncbi.nlm.nih.gov/pubmed/34627382
http://dx.doi.org/10.1186/s13287-021-02594-1
_version_ 1784580713493823488
author Elhussieny, Ahmed
Nogami, Ken’ichiro
Sakai-Takemura, Fusako
Maruyama, Yusuke
Takemura, Natsumi
Soliman, Wael Talaat
Takeda, Shin’ichi
Miyagoe-Suzuki, Yuko
author_facet Elhussieny, Ahmed
Nogami, Ken’ichiro
Sakai-Takemura, Fusako
Maruyama, Yusuke
Takemura, Natsumi
Soliman, Wael Talaat
Takeda, Shin’ichi
Miyagoe-Suzuki, Yuko
author_sort Elhussieny, Ahmed
collection PubMed
description BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe X-linked recessive disease caused by mutations in the dystrophin gene. Transplantation of myogenic stem cells holds great promise for treating muscular dystrophies. However, poor engraftment of myogenic stem cells limits the therapeutic effects of cell therapy. Mesenchymal stem cells (MSCs) have been reported to secrete soluble factors necessary for skeletal muscle growth and regeneration. METHODS: We induced MSC-like cells (iMSCs) from induced pluripotent stem cells (iPSCs) and examined the effects of iMSCs on the proliferation and differentiation of human myogenic cells and on the engraftment of human myogenic cells in the tibialis anterior (TA) muscle of NSG-mdx(4Cv) mice, an immunodeficient dystrophin-deficient DMD model. We also examined the cytokines secreted by iMSCs and tested their effects on the engraftment of human myogenic cells. RESULTS: iMSCs promoted the proliferation and differentiation of human myogenic cells to the same extent as bone marrow-derived (BM)-MSCs in coculture experiments. In cell transplantation experiments, iMSCs significantly improved the engraftment of human myogenic cells injected into the TA muscle of NSG-mdx(4Cv) mice. Cytokine array analysis revealed that iMSCs produced insulin-like growth factor-binding protein 2 (IGFBP2), urokinase-type plasminogen activator receptor (uPAR), and brain-derived neurotrophic factor (BDNF) at higher levels than did BM-MSCs. We further found that uPAR stimulates the migration of human myogenic cells in vitro and promotes their engraftment into the TA muscles of immunodeficient NOD/Scid mice. CONCLUSIONS: Our results indicate that iMSCs are a new tool to improve the engraftment of myogenic progenitors in dystrophic muscle. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02594-1.
format Online
Article
Text
id pubmed-8501581
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85015812021-10-20 Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR) Elhussieny, Ahmed Nogami, Ken’ichiro Sakai-Takemura, Fusako Maruyama, Yusuke Takemura, Natsumi Soliman, Wael Talaat Takeda, Shin’ichi Miyagoe-Suzuki, Yuko Stem Cell Res Ther Research BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe X-linked recessive disease caused by mutations in the dystrophin gene. Transplantation of myogenic stem cells holds great promise for treating muscular dystrophies. However, poor engraftment of myogenic stem cells limits the therapeutic effects of cell therapy. Mesenchymal stem cells (MSCs) have been reported to secrete soluble factors necessary for skeletal muscle growth and regeneration. METHODS: We induced MSC-like cells (iMSCs) from induced pluripotent stem cells (iPSCs) and examined the effects of iMSCs on the proliferation and differentiation of human myogenic cells and on the engraftment of human myogenic cells in the tibialis anterior (TA) muscle of NSG-mdx(4Cv) mice, an immunodeficient dystrophin-deficient DMD model. We also examined the cytokines secreted by iMSCs and tested their effects on the engraftment of human myogenic cells. RESULTS: iMSCs promoted the proliferation and differentiation of human myogenic cells to the same extent as bone marrow-derived (BM)-MSCs in coculture experiments. In cell transplantation experiments, iMSCs significantly improved the engraftment of human myogenic cells injected into the TA muscle of NSG-mdx(4Cv) mice. Cytokine array analysis revealed that iMSCs produced insulin-like growth factor-binding protein 2 (IGFBP2), urokinase-type plasminogen activator receptor (uPAR), and brain-derived neurotrophic factor (BDNF) at higher levels than did BM-MSCs. We further found that uPAR stimulates the migration of human myogenic cells in vitro and promotes their engraftment into the TA muscles of immunodeficient NOD/Scid mice. CONCLUSIONS: Our results indicate that iMSCs are a new tool to improve the engraftment of myogenic progenitors in dystrophic muscle. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02594-1. BioMed Central 2021-10-09 /pmc/articles/PMC8501581/ /pubmed/34627382 http://dx.doi.org/10.1186/s13287-021-02594-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Elhussieny, Ahmed
Nogami, Ken’ichiro
Sakai-Takemura, Fusako
Maruyama, Yusuke
Takemura, Natsumi
Soliman, Wael Talaat
Takeda, Shin’ichi
Miyagoe-Suzuki, Yuko
Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR)
title Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR)
title_full Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR)
title_fullStr Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR)
title_full_unstemmed Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR)
title_short Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR)
title_sort mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (upar)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501581/
https://www.ncbi.nlm.nih.gov/pubmed/34627382
http://dx.doi.org/10.1186/s13287-021-02594-1
work_keys_str_mv AT elhussienyahmed mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar
AT nogamikenichiro mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar
AT sakaitakemurafusako mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar
AT maruyamayusuke mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar
AT takemuranatsumi mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar
AT solimanwaeltalaat mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar
AT takedashinichi mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar
AT miyagoesuzukiyuko mesenchymalstemcellsderivedfromhumaninducedpluripotentstemcellsimprovetheengraftmentofmyogeniccellsbysecretingurokinasetypeplasminogenactivatorreceptorupar